Environmental Aspects in Price and Reimbursement Decisions of Medicines—A Scoping Review

Key Points

• This scoping review aims to examine how environmental aspects are considered in the pricing and reimbursement decisions of medicines.
• Conducted electronic searches across multiple databases and agency websites.
• Included publications from 2013 to 2023 focusing on developed country settings.
• Identified means of integrating environmental aspects into P&R, including conceptual proposals and few implemented examples.
• Of 4476 publications reviewed, 21 publications met inclusion criteria.
• Identified six approaches to include environmental aspects in P&R: HTA integration, reimbursement and pricing criteria, environmental classification, regulation, and delinkage models.
• Challenges noted included data availability, valuation methods, incentive design, and political feasibility.